Indivior (United States)
Indivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction. It is listed on the London Stock Exchange and on the NASDAQ Global Select Market. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Indivior (United States), United States, covering academic research published from 2001 to 2024. Read More.
Open Access Percentage
59%
Total
Publications
129
Total Open
Publications
76
Total
Citations
2.6K
Open Access
Percentage
59%
Total
Publications
129
Total Open
Publications
76
Total
Citations
2.6K
Breakdown
Publisher Open
19%
Both
33%
Other Platform Open
6%
Closed
42%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 35%
23
Hybrid 44%
29
No Guarantees 21%
14
Other Platform Open
Domain 80%
41
Institution 25%
13
Other Internet 10%
5
Preprint 0%
0
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 41 |
DOI | Other Internet | 5 |
Royal Netherlands Academy of Arts and Sciences | Institution | 3 |
Washington University in St. Louis | Institution | 2 |
University of Trento | Institution | 2 |
University College of Arts Crafts and Design | Institution | 2 |
universiteitleiden.nl OAI-PMH Repository | Institution | 2 |
Europe PMC | Domain | 2 |
Virginia Tech | Institution | 1 |
University of St Andrews | Institution | 1 |